LRH-1 modulators (Orphagen)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameLRH-1 modulators (Orphagen)
Drug Alias Nameliver receptor homolog-1 modulators (Orphagen)orphan nuclear receptor modulators (Orphagen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor subfamily 5 group A member 2 modulators
TargetsNuclear receptor subfamily 5 group A member 2
Therapy Area/IndicationsHypercholesterolemiaCholestasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOrphagen Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrphagen Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHypercholesterolemiaCholestasis

Other Information

ATC CodeN/A
Related LinksN/A